Can alkaline phosphatase be elevated in Wilson disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Alkaline Phosphatase in Wilson Disease: Characteristically Low, Not Elevated

Alkaline phosphatase is typically LOW or markedly subnormal in Wilson disease, particularly in acute liver failure presentations, not elevated. This is a critical diagnostic feature that distinguishes Wilson disease from other causes of liver failure.

Acute Liver Failure Presentation

In acute liver failure due to Wilson disease, alkaline phosphatase is characteristically markedly subnormal (typically <40 IU/L), accompanied by only modest transaminase elevations (typically <2000 IU/L). 1, 2 This pattern is so distinctive that it serves as a key diagnostic clue.

Diagnostic Ratios

The low alkaline phosphatase pattern forms the basis of highly specific diagnostic ratios:

  • An alkaline phosphatase-to-total bilirubin ratio <2 strongly suggests Wilson disease in acute liver failure, with studies showing 100% sensitivity and specificity when this cutoff is applied 2, 3, 4
  • An alkaline phosphatase-to-total bilirubin ratio <4 yields 94% sensitivity and 96% specificity for diagnosing fulminant Wilson disease 3
  • The AST/ALT ratio is typically >2.2 (sensitivity 94%, specificity 86%) in fulminant Wilson disease 3

Clinical Context

Suspicion for acute Wilson disease should be particularly high in patients presenting with deep jaundice, Coombs-negative hemolytic anemia, low hemoglobin, low cholinesterase, only mildly increased transaminases, and LOW alkaline phosphatase. 1, 5 This constellation occurs because massive hepatocyte necrosis with copper-mediated inhibition of alkaline phosphatase activity characterizes the acute presentation 6.

Chronic Presentations

In chronic hepatitis and cirrhosis presentations of Wilson disease, alkaline phosphatase levels are typically normal or only mildly elevated, not markedly elevated like in primary cholestatic diseases 1, 5

Critical Pitfall to Avoid

Do not dismiss the possibility of Wilson disease in a young patient with acute liver failure simply because you expect elevated alkaline phosphatase in liver disease. The LOW alkaline phosphatase is the hallmark, and failure to recognize this pattern can delay life-saving liver transplantation 2, 6. The female-to-male ratio in acute Wilson disease is 4:1, and untreated acute liver failure from Wilson disease carries nearly 95% mortality 5.

Diagnostic Limitations

While the alkaline phosphatase-to-bilirubin ratio is highly useful, conventional Wilson disease testing (ceruloplasmin, serum copper) is less reliable in acute liver failure settings, with ceruloplasmin showing only 21-56% sensitivity depending on measurement method 3. The low alkaline phosphatase pattern combined with clinical features provides more rapid and accurate diagnosis 3, 4.

References

Guideline

easl clinical practice guidelines: wilson's disease.

Journal of Hepatology, 2012

Guideline

Liver Disease Manifestations in Wilson's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Considerations for Elevated PLP with Low Alkaline Phosphatase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.